Previous 10 | Next 10 |
Gainers: Reviva Pharmaceuticals RVPH +41%, Ocugen OCGN +22%, Axsome Therapeutics AXSM +12%, AcelRx Pharmaceuticals (ACRX) +9%, Voyager Therapeutics VYGR +8%.Losers: MiMedx (MDXG) -9%, Shineco (TYHT) -8%, Brooklyn ImmunoTherapeut...
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical Procedure PR Newswire REDWOOD CITY, Calif. , April 8, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a speci...
AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors PR Newswire REDWOOD CITY, Calif. , March 31, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the d...
AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Following Use of DSUVIA® for Acute Pain in Hospital Settings PR Newswire REDWOOD CITY, Calif. , March 25, 2021 /PRNewswire/ -- Ace...
AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap Conference PR Newswire REDWOOD CITY, Calif. , March 22, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused o...
CleanSpark (CLSK) -24% on raising $200M capital via equity offering.Takung Art (TKAT) -20%.Oriental Culture Holding (OCG) -24%.Sigma Labs (SGLB) -16%.Zynerba Pharmaceuticals (ZYNE) -14%.Solid Biosciences (SLDB) -15% after reports mid-stage data in Duchenne muscular dystrop...
AcelRx Pharmaceuticals, Inc. (ACRX) Q4 2020 Earnings Conference Call March 15, 2020 04:30 PM ET Company Participants Raffi Asadorian - Chief Financial Officer Pam Palmer - Chief Medical Officer Steve Yun - Physician Expert in Oral & Dental Anesthesiology Conference Call Participants Brand...
AcelRx Pharmaceuticals (ACRX) shares were trading down nearly 6% during after-market trading as the company posted fourth-quarter revenue that missed Wall Street estimates, and provided financial forecast for the full-year.The company's fourth-quarter revenue increased 54% to $0.74M...
Are These Penny Stocks To Buy According To Analysts? We saw another round of bullish sentiment on Wednesday, and investors continue to search for the best penny stocks to watch. The looming issue amongst both blue chip and penny stocks has been the long-term effects of inflation. Gi...
Penny stocks, or stocks with sub-$5 share prices, are rarely worth considering as a long-term investing vehicle. Most of these equities sport depressed shares prices for a very good reason, after all. Low-priced equities, however, can on the rare occasion yield life-changing returns on capi...
News, Short Squeeze, Breakout and More Instantly...
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings Talphera will begin trading on ...
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States PR Newswire Use of CRRT increased during COVID and remained at these higher utilization levels Study results demonst...
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Niyad™ Investigational Device Exemption (IDE) approval by the FDA achieved in third quarter Company plans to begin its Niyad registrational study this quarter with topl...